These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
54 related items for PubMed ID: 1222886
1. A multicenter double blind clinical trial on 3.4.5-trimethoxybenzoiyl-epsilon-aminocaproic acid (C-3) in acute myocardial infarction. Rossi P, Brusca A, di Pretoro L, Fazzini PF, Galassi A, Gentile M, Gramolini C, Lombardi M, Lotto A, Martinelli A, Palma G, Poppi A, Porciello PI, Prati PL. G Ital Cardiol; 1975; 5(6):914-22. PubMed ID: 1222886 [Abstract] [Full Text] [Related]
6. Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Dzavik V, Sleeper LA, Picard MH, Sanborn TA, Lowe AM, Gin K, Saucedo J, Webb JG, Menon V, Slater JN, Hochman JS, SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK Investigators. Am Heart J; 2005 Jun; 149(6):1128-34. PubMed ID: 15976798 [Abstract] [Full Text] [Related]
7. [Clinical features and treatment of cardiogenic shock complicated with acute myocardial infarction]. Zhao YS, Wang SW, Lu CY, Wu XL, Li YF, Liu LL, Yan MY, Cheng R. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):148-50. PubMed ID: 15009960 [Abstract] [Full Text] [Related]
13. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. Breddin K, Loew D, Lechner K, Oberla K, Walter E. Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073 [Abstract] [Full Text] [Related]
15. Methylprednisolone as an intervention following myocardial infarction. The Solu-Medrol Sterile Powder AMI Studies Group. J Int Med Res; 1986 Dec; 14 Suppl 1():1-10. PubMed ID: 2875003 [Abstract] [Full Text] [Related]
16. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients. Dzavík V, Burton JR, Kee C, Teo KK, Ignaszewski A, Lucas AR, Tymchak WJ. Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277 [Abstract] [Full Text] [Related]
17. Acute myocardial infarction in the elderly--the differences compared with the young. Woon VC, Lim KH. Singapore Med J; 2003 Aug; 44(8):414-8. PubMed ID: 14700421 [Abstract] [Full Text] [Related]
18. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. Liu L, Chinese Cardiac Study (CCS-I) Collaborative Group. Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187 [Abstract] [Full Text] [Related]
19. [Ulterior observations on the use of C3 in acute myocardial infarction: 105 patients were treated within the 1st 6 hours after the symptoms started]. Selvini A, Belli C, Corallo S, Gramolini C. Arch Inst Cardiol Mex; 1976 Feb; 46(2):222-31. PubMed ID: 938161 [Abstract] [Full Text] [Related]
20. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS, TRIUMPH Investigators. Am Heart J; 2009 Oct; 158(4):680-7. PubMed ID: 19781431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]